What does CUSIP 09071M106 represent in this 13F holders report?

CUSIP 09071M106 is the security identifier for BLRX - BIOLINERX LTD - SPONSORED ADR used to aggregate holder disclosures.

How many institutions held BLRX - BIOLINERX LTD - SPONSORED ADR in Q1 2017?

26 institutional investors reported BLRX - BIOLINERX LTD - SPONSORED ADR for Q1 2017. Use the holders table for investor-level position and value details.

BIOLINERX LTD - SPONSORED ADR (BLRX)

CUSIP: 09071M106

Q1 2017 13F Holders as of 31 Mar 2017

Security type / class: Equity / SPONSORED ADR
Total 13F shares: 36,331,098
Total 13F value: $34,891,000
Share change: +28,398,421
SEC-reported price per share: $0.96
Number of holders: 26
Value change: +$27,280,642
Number of buys: 16
Number of sells: 5

Security key

09071M106

Report period

Q1 2017

Institutions

Top holders

BLRX full security history Ownership snapshot Full 13F holder table BioLineRx Ltd. SEC filings BioLineRx Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BLRX - BIOLINERX LTD - SPONSORED ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Senvest Management, LLC

Disclosed value leader

Senvest Management, LLC

Comparable rows

0/15

Latest evidence

31 Dec 2016

13F Highest disclosed value: $4,386,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Senvest Management, LLC has the largest disclosed position value at $4.39M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Senvest Management, LLC's linked filing trail.

Disclosed position value Top 5

Senvest Management, LLC $4.39M

ORBIMED ADVISORS LLC $956K

Alyeska Investment Group, L.P. $591K

MORGAN STANLEY $567K

Opaleye Management Inc. $230K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Senvest Management, LLC	13F Company 13F	— denominator unverified	$4,386,000 4,767,619 shares	—	31 Dec 2016
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$956,000 1,038,600 shares	—	31 Dec 2016
Alyeska Investment Group, L.P.	13F Company 13F	— denominator unverified	$591,000 642,421 shares	—	31 Dec 2016
MORGAN STANLEY	13F Company 13F	— denominator unverified	$567,000 616,124 shares	—	31 Dec 2016
Opaleye Management Inc.	13F Company 13F	— denominator unverified	$230,000 250,000 shares	—	31 Dec 2016
DEUTSCHE BANK AG\	13F Company 13F	— denominator unverified	$196,000 213,696 shares	—	31 Dec 2016

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

36,331,098

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Holder diff

Investor	Q1 2017 Shares	Q1 2017 Shares	Share Diff	Share Chg %	Q1 2017 value	Q1 2017 value	Value change	Value Chg %